Carmila S.A. - CARM.PA

CARM.PA Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
CARM.PA	0.6	3.1	3.2	-3.5	-0.5	2.5	14.4	-6.2	-23.4	-76.6
S&P 500	-0.5	1.2	2.9	5.4	13.0	21.8	31.6	85.9	198.9	34104.6

Compare CARM.PA with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	CARM.PA
name	Carmila S.A.
price	16.7
changes percentage	0.6024
change	0.1
day low	16.52
day high	16.8
year high	18.82
year low	14.72
market cap	2355074113
price avg 50	16.084
price avg 200	16.7421
exchange	EURONEXT
volume	44594
avg volume	62234
open	16.7
previous close	16.6
eps	0.38
pe	43.95
earnings announcement	2025-02-11T15:00:00.000+0000
shares outstanding	141022402
timestamp	2025-01-31 16:37:09

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 36.7%

Overall Quarterly Financial Health: 55.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	486119000	472685000	2.84
gross profit	364529000	361058000	0.96
gross profit ratio	0.75	0.76	-1.83
research and development expenses	0	0.46	-100.00
operating expenses	76127000	72349000	5.22
interest income	27528000	2053000	1240.87
interest expense	106340000	76909000	38.27
ebitda	290292000	289700000	0.20
ebitdaratio	0.6	0.61	-2.56
operating income	288402000	288709000	-0.11
operating income ratio	0.59	0.61	-2.87
net income	2778000	219329000	-98.73
net income ratio	0.01	0.46	-98.77
eps	0.02	1.52	-98.72

Overall Score of Annual Income Statement

None

Detailed Analysis

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	265357000	227798000	16.49
gross profit	187502000	179163000	4.65
gross profit ratio	0.71	0.79	-10.16
research and development expenses	0	13358000	-100.00
operating expenses	-41405000	174703999	-123.70
interest income	26381000	13358000	97.49
interest expense	0	57787000	-100.00
ebitda	147162000	139048000	5.84
ebitdaratio	0.55	0.61	-9.14
operating income	146097000	137795000	6.02
operating income ratio	0.55	0.6	-8.98
net income	84497000	-32085000	363.35
net income ratio	0.32	-0.14	326.08
eps	0.6	-0.23	360.87

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 265 million in 2024Q2 from 228 million in 2023Q4 representing a change of 16.49%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 188 million in 2024Q2 from 179 million in 2023Q4 representing a change of 4.65%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to -41 million in 2024Q2 from 175 million in 2023Q4 representing a change of -123.7%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 147 million in 2024Q2 from 139 million in 2023Q4 representing a change of 5.84%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 146 million in 2024Q2 from 138 million in 2023Q4 representing a change of 6.02%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 84 million in 2024Q2 from -32 million in 2023Q4 representing a change of 363.35%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.6 in 2024Q2 from 0.6 in 2023Q4 representing a change of 360.87%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q2 from 13 million in 2023Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	6730544000	6513324000	3.34
total liabilities	3437285000	3005872000	14.35
total equity	3293259000	3507452000	-6.11
cash and cash equivalents	860194000	356707000	141.15
short term investments	1269000	640000	98.28
long term investments	83162000	138608000	-40.00
total current assets	1045040000	536896000	94.64
total non current assets	5685504000	5900633000	-3.65
total current liabilities	734048000	240894000	204.72
total non current liabilities	2703237000	2500451000	8.11
common stock	854646000	863094000	-0.98
retained earnings	769174000	765084000	0.53
total debt	3050450000	2586450000	17.94

Overall Score of Annual Balance Sheet

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 6,731 million in 2023 from 6,513 million in 2022 representing a change of 3.34%. Suggesting a growth in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 860 million in 2023 from 357 million in 2022 representing a change of 141.15%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 1 million in 2023 from 1 million in 2022 representing a change of 98.28%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 1,045 million in 2023 from 537 million in 2022 representing a change of 94.64%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 769 million in 2023 from 765 million in 2022 representing a change of 0.53%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 3,437 million in 2023 from 3,006 million in 2022 representing a change of 14.35%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 3,293 million in 2023 from 3,507 million in 2022 representing a change of -6.11%. This indicates a decrease in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities increased to 734 million in 2023 from 241 million in 2022 representing a change of 204.72%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 855 in 2023 from 863 in 2022 representing a change of -0.98%. This indicates a decrease in ownership interest.

  Total Debt: Total Debt increased to 3,050 million in 2023 from 2,586 million in 2022 representing a change of 17.94%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	6688421000	6730544000	-0.63
total liabilities	3473819000	3437285000	1.06
total equity	3214602000	3293259000	-2.39
cash and cash equivalents	777409000	860194000	-9.62
short term investments	0	0	NaN
long term investments	0	114098000	-100.00
total current assets	0	1045040000	-100.00
total non current assets	0	5685504000	-100.00
total current liabilities	541918000	734048000	-26.17
total non current liabilities	2889493000	2703237000	6.89
common stock	854646000	854646000	0.00
retained earnings	811332000	769174000	5.48
total debt	3019543000	3024142000	-0.15

Overall Score of Quarterly Balance Sheet

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 6,688 million in 2024Q2 from 6,731 million in 2023Q4 representing a change of -0.63%. Suggesting a decrease in asset holdings.

  Total Liabilities: Total Liabilities increased to 3,474 million in 2024Q2 from 3,437 million in 2023Q4 representing a change of 1.06%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 3,215 million in 2024Q2 from 3,293 million in 2023Q4 representing a change of -2.39%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 777 million in 2024Q2 from 860 million in 2023Q4 representing a change of -9.62%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 0 million in 2024Q2 from 1,045 million in 2023Q4 representing a change of -100.0%. This indicates a worsen liquidity position.

• 📈 Positive Indicators

  Total Current Liabilities: Total Current Liabilities decreased to 542 million in 2024Q2 from 734 million in 2023Q4 representing a change of -26.17%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 811 million in 2024Q2 from 769 million in 2023Q4 representing a change of 5.48%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 3,020 million in 2024Q2 from 3,024 million in 2023Q4 representing a change of -0.15%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	503494000	118439000	325.11
operating cash flow	276053000	261406000	5.60
free cash flow	261550000	236372000	10.65
capital expenditure	-14503000	-25034000	42.07
depreciation and amortization	1890000	991000	90.72
deferred income tax	0	1582000	-100.00
stock based compensation	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	128306999	146030000	-12.14
investments in property plant and equipment	-14503000	-25034000	42.07
net cash used for investing activites	56668000	30457000	86.06
debt repayment	421843000	374000	112692.25
common stock issued	0	0	NaN
common stock repurchased	-20466000	-29845000	31.43
dividends paid	-166698000	-143555000	-16.12
net cash used provided by financing activities	170773000	-173362000	198.51
cash at end of period	860181000	356707000	141.14
accounts receivables	0	0	NaN
cash at beginning of period	356687000	238268000	49.70

Overall Score of Annual Cashflow Statement

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 503 million in 2023 from 118 million in 2022 representing a change of 325.11%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 276 million in 2023 from 261 million in 2022 representing a change of 5.6%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 262 million in 2023 from 236 million in 2022 representing a change of 10.65%. This indicates an increase in cash generated after accounting for capital expenditures.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -15 million in 2023 from -25 million in 2022 representing a change of 42.07%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Dividends Paid: Dividends Paid decreased to -167 million in 2023 from -144 million in 2022 representing a change of -16.12%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	108231000	104238000	3.83
free cash flow	105460000	97108000	8.60
capital expenditure	-2771000	-7130000	61.14
depreciation and amortization	1065000	1253000	-15.00
deferred income tax	0	2115000	-100.00
stock based compensation	0	0	NaN
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	16961000	33330000	-49.11
investments in property plant and equipment	-2771000	-7130000	61.14
net cash used for investing activites	-13774000	-462000	-2881.39
debt repayment	0	65037999	-100.00
common stock issued	0	0	NaN
common stock repurchased	-6374000	-446000	-1329.15
dividends paid	-170708000	0	NaN
net cash used provided by financing activities	-177237000	64428000	-375.09
net change in cash	-82785000	168184000	-149.22
cash at end of period	777409000	860194000	-9.62
cash at beginning of period	860194000	692010000	24.30

Overall Score of Quarterly Cashflow Statement

0.4 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -83 million in 2024Q2 from 168 million in 2023Q4 representing a change of -149.22%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -3 million in 2024Q2 from -7 million in 2023Q4 representing a change of 61.14%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Dividends Paid: Dividends Paid decreased to -171 million in 2024Q2 from 0 million in 2023Q4 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 108 million in 2024Q2 from 104 million in 2023Q4 representing a change of 3.83%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 105 million in 2024Q2 from 97 million in 2023Q4 representing a change of 8.6%. This indicates an increase in cash generated after accounting for capital expenditures.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	3.4	3.28	3.84
net income per share	0.02	1.52	-98.72
operating cash flow per share	1.93	1.81	6.63
free cash flow per share	1.83	1.64	11.72
cash per share	6.03	2.48	143.41
book value per share	23.06	24.32	-5.20
tangible book value per share	23.04	24.3	-5.15
shareholders equity per share	23.02	24.28	-5.20
interest debt per share	22.1	18.47	19.68
market cap	2225256547.54	1923785625.44	15.67
enterprise value	4415512547.54	4153528625.44	6.31
pe ratio	801.03	8.77	9032.45
price to sales ratio	4.58	4.07	12.47
pocfratio	8.06	7.36	9.53
pfcf ratio	8.51	8.14	4.54
pb ratio	0.68	0.55	23.19
ptb ratio	0.68	0.55	23.19
ev to sales	9.08	8.79	3.37
enterprise value over ebitda	15.21	14.34	6.09
ev to operating cash flow	16.0	15.89	0.67
ev to free cash flow	16.88	17.57	-3.93
earnings yield	0.0	0.11	-98.91
free cash flow yield	0.12	0.12	-4.34
debt to equity	0.93	0.74	25.61
debt to assets	0.45	0.4	14.13
net debt to ebitda	7.55	7.7	-1.97
current ratio	1.42	2.23	-36.12
interest coverage	2.71	3.75	-27.75
income quality	99.37	1.19	8237.59
dividend yield	0.07	0.07	0.39
payout ratio	60.01	0.65	9068.03
sales general and administrative to revenue	0	0.09	-100.00
research and ddevelopement to revenue	0	0.0	-100.00
intangibles to total assets	0.0	0.0	-48.35
capex to operating cash flow	0.05	0.1	-45.14
capex to revenue	0.03	0.05	-43.67
capex to depreciation	7.67	25.26	-69.62
stock based compensation to revenue	0	0	NaN
graham number	3.17	28.83	-88.99
roic	0.01	0.05	-72.21
return on tangible assets	0.0	0.03	-98.77
graham net net	-17.47	-17.43	-0.26
working capital	310992000	296002000	5.06
tangible asset value	3291318000	3503815000	-6.06
net current asset value	-2392245000	-2468976000	3.11
invested capital	325750000	302615000	7.65
average receivables	143285500	179280500	-20.08
average payables	19562000	20352500	-3.88
average inventory	0.5	1	-50.00
days sales outstanding	80.04	138.97	-42.41
days payables outstanding	58.25	64.48	-9.67
days of inventory on hand	0	0.0	-100.00
receivables turnover	4.56	2.63	73.63
payables turnover	6.27	5.66	10.71
inventory turnover	0	111627000	-100.00
roe	0.0	0.06	-98.65
capex per share	0.1	0.17	-41.51

• Negative

  ROE: Return on Equity (ROE) decreased to 0.00 on 2023-12-31 from 0.06 on 2022-12-31, representing a change of -98.65%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 801.03 on 2023-12-31 from 8.77 on 2022-12-31, representing a change of 9032.45%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.42 on 2023-12-31 from 2.23 on 2022-12-31, representing a change of -36.12%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.93 on 2023-12-31 from 0.74 on 2022-12-31, representing a change of 25.61%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
CARM.PA
calendar year	2024	2023	NaN
revenue per share	1.87	1.6	16.79
net income per share	0.6	-0.23	364.03
operating cash flow per share	0.76	0.73	4.10
free cash flow per share	0.74	0.68	8.88
cash per share	5.48	6.05	-9.39
book value per share	22.66	23.15	-2.14
tangible book value per share	22.64	23.14	-2.14
shareholders equity per share	22.62	23.12	-2.14
interest debt per share	21.28	21.67	-1.77
market cap	2255708752.5	2216001684.78	1.79
enterprise value	4497842752.5	4379949684.78	2.69
pe ratio	6.67	-17.27	138.65
price to sales ratio	8.5	9.73	-12.62
pocfratio	20.84	21.26	-1.96
pfcf ratio	21.39	22.82	-6.27
pb ratio	0.7	0.67	4.29
ptb ratio	0.7	0.67	4.29
ev to sales	16.95	19.23	-11.84
enterprise value over ebitda	30.56	31.5	-2.97
ev to operating cash flow	41.56	42.02	-1.10
ev to free cash flow	42.65	45.1	-5.44
earnings yield	0.04	-0.01	358.72
free cash flow yield	0.05	0.04	6.69
debt to equity	0.94	0.92	2.30
debt to assets	0.45	0.45	0.48
net debt to ebitda	15.24	15.56	-2.10
current ratio	0	1.42	-100.00
interest coverage	0	2.38	-100.00
income quality	1.28	-3.25	139.43
dividend yield	0.08	0	NaN
payout ratio	2.02	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0.06	-100.00
intangibles to total assets	0.0	0.0	3.64
capex to operating cash flow	0.03	0.07	-62.57
capex to revenue	0.01	0.03	-66.64
capex to depreciation	2.6	5.69	-54.28
stock based compensation to revenue	0	0	NaN
graham number	17.41	10.83	60.74
roic	0	0.02	-100.00
return on tangible assets	0.01	-0.0	365.01
graham net net	-17.89	-17.16	-4.25
working capital	-541918000	310992000	-274.25
tangible asset value	3212603000	3291318000	-2.39
net current asset value	-3473819000	-2392245000	-45.21
invested capital	-525972000	325750000	-261.46
average receivables	196995000	188556000	4.48
average payables	9701500	19170500	-49.39
average inventory	0	0	NaN
days sales outstanding	71.82	72.0	-0.26
days payables outstanding	0	35.91	-100.00
days of inventory on hand	0	0	NaN
receivables turnover	1.25	1.25	0.26
payables turnover	0	2.51	-100.00
inventory turnover	0	0	NaN
roe	0.03	-0.01	369.82
capex per share	0.02	0.05	-61.04

• Negative

  ROE: Return on Equity (ROE) increased to 0.03 on 2024-06-30 Q2 from -0.01 on 2023-12-31 Q4, representing a change of 369.82%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio decreased to 0.00 on 2024-06-30 Q2 from 1.42 on 2023-12-31 Q4, representing a change of -100.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 6.67 on 2024-06-30 Q2 from -17.27 on 2023-12-31 Q4, representing a change of 138.65%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.94 on 2024-06-30 Q2 from 0.92 on 2023-12-31 Q4, representing a change of 2.30%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 13.48 which is lower than current price 16.7, indicates the company may be overvalued.